1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [munoorinn@gmail.com].
   


6. For how long will this data be available start date provided 01-01-2024 and end date provided 01-01-2029?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - Nil

Background of the study

Suicide is a significant public health issue worldwide, particularly in India, where its multi-factorial etiology affects both the health and social sectors. Since, Substance use is one of the prominent risk factors for suicide, more efforts to address suicidality in the population needs to be initiated. Also, best of our knowledge, the current treatment is not addressing the preventive measures for suicide. It is crucial to develop interventions to address suicide prevention in this view. The current study aims to develop and pilot testing a suicide prevention program for persons with substance use disorder.

Method

The study will be adopted a mixed-method research design. The first two phases would adopt a qualitative research design to review the literature and need assessment to develop the suicide prevention program. The third phase would be using a Quasi-experimental mixed method research design, a waitlist comparison group with pretest-posttest, and a three month follow up to pilot testing of the developed programme. To recruit the participants in the quantitative and qualitative phases will adopt the consecutive sampling and the purposive sampling method, respectively. The persons taking treatment from the Centre for Addiction Medicine (CAM) NIMHANS are considered the study population. The study will be carried out in the IP service of CAM.

Implication

The study focuses on developing suicide prevention initiatives in addiction settings, considering that persons with substance use disorder are at high risk of suicide attempts and suicide. The current study addresses the gap between suicide prevention in addiction treatment. Primarily, the suicide prevention programme might be helping the participants in improving their help seeking for reducing suicidal behaviours. It also enhance knowledge and reduce the stigma toward suicide.

Conclusion

Contextually appropriate and culturally sensitive suicide prevention programmes can be protective factors preventing suicide attempts and suicide in post discharging scenarios. Inculcating the programme to the regular deaddiction treatment will be an effective strategy for suicide prevention. Additionally, the study outcome can be an integral part of the national suicide prevention strategy.